DEA warns that ADHD overprescription could be as bad as OPIOID CRISIS in stinging letter to pharmaceutical giants it accuses of ‘aggressive marketing’ – as users rise 10% in a year to 41 million

The Drug Enforcement Administration (DEA) has expressed concern that ‘aggressive marketing practices’ by telehealth companies may be contributing to excessive prescriptions for medications used to treat attention deficit hyperactivity disorder (ADHD), according to a letter from the agency. 

While the letter does not mention specific companies, it is believed to refer to telehealth companies such as Cerebral Inc. and Done Global Inc., whose prescribing practices have reportedly been under investigation by the DEA after blitzing social media with online adverts on platforms including Instagram and Facebook. 

Read more…